Building an ACE2 Receptor Trap for Pandemic Pathogens
Researchers led by the University of California, San Francisco and the University of Alberta, Edmonton have engineered angiotensin-converting enzyme II ...
Tag: Convalescent Serum
Two Studies Show COVID-19 Antibodies Persist for Months
More than 8 million people in the United States have now tested positive for COVID-19. For those who’ve recovered, many ...
Finding the Golden Window for Collecting COVID-19 Survivor Antibodies
In recovering COVID-19 patients, antibodies fade quickly, but adequate time must be given to clear viral particles before plasma collection ...
DoD Researchers Collaborate on Universal Antibody Test for COVID-19
Researchers from the U.S. Army Futures Command, in collaboration with Houston Methodist, Pennsylvania State University, and UT Austin, tested alternative ...
NIH Expands COVID-19 Convalescent Plasma Clinical Trials
The National Institutes of Health (NIH) today announced it is expanding enrollment in two existing clinical trials to further evaluate ...
UT Austin Spearheads Scalable, ELISA Antibody Test for SARS-CoV-2
In collaboration with UT Austin, Penn State University and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), study ...
Convalescent Plasma Therapy: Johns Hopkins Releases Guidebook, Penn Medicine and UChicago Start Trials
A team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centers rapidly scale up ...
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients
The U.S. Department of Health and Human Services (HHS) will collaborate with multiple non-government organizations on the development of convalescent ...
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19
Amgen and Adaptive Biotechnologies announced a collaboration aimed at combing expertise to discover and develop fully human neutralizing antibodies targeting ...
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19
Emergent BioSolutions Inc. announced today that it has entered into a formal partnership with the U.S. government to expedite development of a ...
WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment
With no drugs or vaccines yet approved for COVID-19 and the number of U.S. cases increasing by the thousands every ...
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients
The FDA is facilitating access to convalescent plasma, antibody-rich blood products that are taken from blood donated by people who ...
Serological Assay to Detect SARS-CoV-2 Seroconversion in Humans
We currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies, of critical importance to determine seroprevalence in a given ...
Using Antibodies from COVID-19 Survivors to Protect Healthcare Workers and Patients
Countries fighting outbreaks of the novel coronavirus disease COVID-19 should consider using the antibodies of people who have recovered from ...
